Vivos Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Vivos Therapeutics, Inc. (VVOS) reported Basic Shares Outstanding (Weighted Average) of 17.68 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.68M shares, a 94.58% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 14.63M shares, a 70.26% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 12.42M shares, a 71.76% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 10.96M shares, a 65.73% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 10.27M shares, a 104.66% increase from fiscal 2024.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 5.02M shares, a 311.67% increase from fiscal 2023.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.22M shares, a 32.46% increase from fiscal 2022.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 920.59K shares, a 100.00% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.68M shares 10-Q · filed 2026-08-14 | 16.17M shares 10-Q · filed 2026-08-14 | 14.91M shares derived: average of 3 quarters · filed 2026-08-14 | 13.93M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 14.63M shares 10-Q · filed 2026-05-20 | 13.53M shares derived: average of 2 quarters · filed 2026-05-20 | 12.67M shares derived: average of 3 quarters · filed 2026-05-20 | 11.78M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 12.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 11.69M shares derived: average of 2 quarters · filed 2026-04-15 | 10.82M shares derived: average of 3 quarters · filed 2026-08-14 | 10.27M shares 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | 10.96M shares 10-Q · filed 2025-11-19 | 10.03M shares derived: average of 2 quarters · filed 2026-08-14 | 9.56M shares 10-Q · filed 2025-11-19 | 8.97M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 9.09M shares 10-Q · filed 2026-08-14 | 8.84M shares 10-Q · filed 2026-08-14 | 8.31M shares derived: average of 3 quarters · filed 2026-08-14 | 7.88M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 8.60M shares 10-Q · filed 2026-05-20 | 7.91M shares derived: average of 2 quarters · filed 2026-05-20 | 7.48M shares derived: average of 3 quarters · filed 2026-05-20 | 6.42M shares derived: average of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | 7.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 6.92M shares derived: average of 2 quarters · filed 2026-04-15 | 5.69M shares derived: average of 3 quarters · filed 2026-04-15 | 5.02M shares 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | 6.62M shares 10-Q · filed 2025-11-19 | 4.92M shares derived: average of 2 quarters · filed 2025-11-19 | 4.28M shares 10-Q · filed 2025-11-19 | 3.39M shares derived: average of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | 3.23M shares 10-Q · filed 2025-08-19 | 2.77M shares 10-Q · filed 2025-08-19 | 2.32M shares derived: average of 3 quarters · filed 2025-08-19 | 2.04M shares derived: average of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | 2.31M shares 10-Q · filed 2025-05-15 | 1.86M shares derived: average of 2 quarters · filed 2025-05-15 | 1.64M shares derived: average of 3 quarters · filed 2025-05-15 | 1.53M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 1.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.31M shares derived: average of 2 quarters · filed 2025-03-31 | 1.27M shares derived: average of 3 quarters · filed 2025-03-31 | 1.22M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 1.20M shares 10-Q · filed 2024-11-14 | 1.20M shares derived: average of 2 quarters · filed 2024-11-14 | 1.15M shares 10-Q · filed 2024-11-14 | 1.13M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 1.20M shares 10-Q · filed 2024-08-14 | 29.93M shares 10-Q · filed 2023-08-16 | 1.13M shares 10-Q · filed 2024-08-14 | 28.25M shares 10-Q · filed 2023-08-16 | 1.11M shares derived: average of 3 quarters · filed 2024-08-14 | 1.04M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 990.67K shares 10-Q · filed 2024-05-14 | 24.76M shares 10-Q · filed 2023-06-08 | 1.06M shares derived: average of 2 quarters · filed 2024-07-30 | 991.38K shares derived: average of 3 quarters · filed 2024-07-30 | 6.05M shares derived: average of 4 quarters · filed 2024-07-30 | |||
| 2022-12-31 | 1.13M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | 991.74K shares derived: average of 2 quarters · filed 2024-07-30 | 7.74M shares derived: average of 3 quarters · filed 2024-07-30 | 920.59K shares 10-K/A · filed 2024-07-30 | 23.01B shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 849.45K shares 10-Q · filed 2023-11-14 | 21.23B shares 10-Q · filed 2022-12-20 | 11.04M shares derived: average of 2 quarters · filed 2023-11-14 | 849.45K shares 10-Q · filed 2023-11-14 | 21.23B shares 10-Q · filed 2022-12-20 | 5.77B shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 21.23M shares 10-Q · filed 2023-08-16 | 21.23B shares 10-Q · filed 2022-12-20 | 21.23M shares 10-Q · filed 2023-08-16 | 21.23B shares 10-Q · filed 2022-12-20 | 7.69B shares derived: average of 3 quarters · filed 2023-08-16 | 10.98B shares derived: average of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | 21.23M shares 10-Q · filed 2023-06-08 | 21.23M shares 10-Q · filed 2022-05-16 | 11.53B shares derived: average of 2 quarters · filed 2023-06-08 | 14.63B shares derived: average of 3 quarters · filed 2023-06-08 | 16.15B shares derived: average of 4 quarters · filed 2023-06-08 | |||
| 2021-12-31 | 23.03B shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 21.93B shares derived: average of 2 quarters · filed 2023-03-30 | 21.53B shares derived: average of 3 quarters · filed 2023-03-30 | 21.23B shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 20.83B shares 10-Q · filed 2022-12-20 | 20.78B shares derived: average of 2 quarters · filed 2022-12-20 | 20.63B shares 10-Q · filed 2022-12-20 | |||||
| 2021-06-30 | 20.74B shares 10-Q · filed 2022-12-20 | 19.48B shares 10-Q · filed 2022-12-20 | ||||||
| 2021-03-31 | 18.21M shares 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |